Biomay AG, of Vienna, and contract research and development company VTU Technology, of Grambach, Austria, said they entered a licensing agreement for the production of recombinant allergens. Under the terms, Biomay will use VTU's Pichia expression strains for commercial production, with VTU receiving royalties based on Biomay´s worldwide sales of the recombinant allergens.